Hemodialysis
Improved dialysis effectivity
With the motorized movement therapy device MOTOmed letto2 dialysis patients benefit from the available time during dialysis. Movement during dialysis can increase “dialysis effectivity”, decrease the amount of toxicants in the blood and improve the blood test results of dialysis patients.
The dialysis patient can train with own muscle power or improve his general condition (strength and endurance) with motor support. Due to the help of the motor and the intelligent active/passive detection of the MOTOmed letto2 even weaker patients or patients with below knee amputations benefit from MOTOmed movement therapy. This movement, which resembles cycling, can help to stabilize the heart, circulation and blood pressure situation. Complications such as fainting, shocks and unconsciousness occur less frequently during dialysis.
Scientific study
Dziubek W, Bulińska K, Rogowski Ƚ, Kusztal M. Three-month endurance training improves functional fitness and knee muscle performance of patients with end stage renal disease (ESRD). Isokinetics and Exercise Science 24 (2016); 237 – 246.
MOTOmed movement therapy
MOTOmed Movement Therapy was developed for people with limited mobility and supports physiotherapy, ergo therapy and sports therapy. Users can train sitting in a wheelchair or from a chair. In supine position, patients use the MOTOmed from the nursing bed or from the therapy bed.
Therapy modes
passive
The effortless motor driven movement is ideal for the regulation of muscle tone, loosening stiff muscles and for early mobilization after long rests. Passive training stimulates blood circulation, digestion and joint flexibility.
motor-supported
In motor-supported movement therapy, the function MOTOmed ServoCycling enables easy transition from passive to active training. A motor-supported movement stimulates strength and endurance even with minimal muscle strength.
active
An active training with own muscle power against finely adjustable resistance levels strengthens leg, arm and upper body muscles and stimulates the cardio-vascular system.
Achieving best therapy goals through interval training
Alternating phases of strain and recreation (intervals) through active and passive training give a higher training stimulus which leads to a better therapy success.
Therapeutic goals
- Promote walking
- Reduce the consequences of lack of movement
- Activate residual muscle strength
- Strengthen the psyche and well-being
- Counteract fatigue
Videos
Scientific studies and research results about the MOTOmed movement therapy during hemodialysis
Anding K., Bär T., Trojniak-Hennig J., Kuchinke S., Krause R., Rost J.M., Halle M. (2015). A structured exercise program during haemodialysis for patients with chronic kidney disease: clinical benefit and long-term adherence. BMJ Open, 5(8)., DOI: 10.1136/bmjopen-2015-008709
Anding- Rost K., Bär T., Trojniak-Hennig J., Krause K. (2010). Der Einfluss von Sporttherapie und körperlicher Leistungsfähigkeit auf die Morbidität und Lebensqualität von Patienten mit chronischer Niereninsuffizienz. MedReport, Nephrologie, 22(34), 9.
Torkington M., MacRae M., Isles C. (2006). Uptake of and adherence to exercise during hospital haemodialysis. Physiotherapie, 92(2), 83-87., DOI: 10.1016/j.physio.2005.08.004
Kouidi E. (2002). Exercise Training in Dialysis Patients: Why, When, and How?. Artificial Organs, 26(12), 1009-1013., DOI: 10.1046/j.1525-1594.2002.00937.x
Dziubek W., Bulińska K., Rogowski Ƚ., Kusztal M., Zembroń-Ƚacny A., Goƚȩbiowski T., Markowska D., Klinger M., Woźniewski M. (2016). Three-month endurance training improves functional fitness and knee muscle performance of patients with end stage renal disease (ESRD). Isokinetics and Exercise Science, 24(3), 237-246., DOI: 10.3233/IES-160623
Dziubek W., Kowalska J., Kusztal M., Rogowski Ƚ., Gołębiowski T., Nikifur M., Szczepańska-Gieracha J., Zembroń- Łacny A., Klinger M., Woźniewski M. (2016). The Level of Anxiety and Depression in Dialysis Patients Undertaking Regular Physical Exercise Training – a Preliminary Study. Kidney Blood Pressure Research, 41(1), 86–98., DOI: 10.1159/000368548